Down-regulating Nrf2 by tangeretin reverses multiple drug resistance to both chemotherapy and EGFR tyrosine kinase inhibitors in lung cancer
Ying Xie, Senling Feng, Fang He, Peiyu Yan, Xiaojun Yao, Xing‐Xing Fan, Elaine Lai‐Han Leung, Hua Zhou
Topics & Concepts
Lung cancerPaclitaxelGefitinibT790MCancer researchDrug resistancePharmacologyChemotherapyMedicineCancerMultiple drug resistanceA549 cellBiologyEpidermal growth factor receptorOncologyInternal medicineMicrobiologyGenomics, phytochemicals, and oxidative stressFungal Biology and ApplicationsPhytochemicals and Antioxidant Activities